CEO David Barrett, JD, noted there has been “a nice uptick” in Q1 in start-up funding compared to the same quarter last year, ...

Somewhere in an operating room this spring, a neurosurgeon did something that has never been done before: while removing a ...

DUBLIN--(BUSINESS WIRE)--The "Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of ...

ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable residual disease (MRD)-negative responses in the first four patients with relapsed ...

The gene therapy landscape has changed dramatically in the past 5 years, and investigators wanted to capture and analyze the details of current and upcoming trials, along with their potential impact ...

For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in ...

Two leading retinal specialists break down MCO-010's 3-year efficacy and safety data, the significance of contralateral eye ...

The cell and gene therapy industry has achieved breakthroughs once thought impossible, translating novel concepts into real therapeutic options for patients. The FDA has now approved 43 cell and gene ...

Collaboration will help employers manage catastrophic financial risk while ensuring access to life-changing treatmentsNEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Aradigm, the market’s first ...

Health systems must prepare for the growing impact of cell and gene therapies by addressing their high costs, complex care pathways, and payer collaboration needs to ensure timely and sustainable ...

Gene and molecular therapy encompasses a suite of approaches that seek to correct or modulate cellular function by altering nucleic acids within living tissues. At its core, gene therapy introduces ...